News
UnitedHealth's RSI Suggests It Is Extremely Oversold
Few stocks get this oversold this quickly, especially mega-cap names like UnitedHealth Group Inc. (NYSE: UNH). After a 45% rally from March into December, the
Unitedhealth Stock: DOJ Probe Triggers 7% Single-Day Plunge
The healthcare insurance giant Unitedhealth experienced a significant market setback on Friday as its stock plummeted more than 7%, deepening the company's recent struggles. The sharp decline came
Unitedhealth Stock: DOJ Probe Triggers 9% Share Plunge
Unitedhealth Group experienced a significant market setback on Friday as its shares plummeted nearly 9% following revelations of a Department of Justice investigation. The probe centers on the
Unitedhealth Stock: DoJ Probe Triggers 11% Share Plunge
The healthcare insurance giant Unitedhealth experienced a dramatic 11% stock decline on Friday following the announcement of a civil fraud investigation by the U.S. Department of Justice (DoJ). The
UnitedHealth Stock: FTC Scrutiny Triggers 4.6% Share Decline
UnitedHealth Group experienced a significant market setback as its shares plummeted 4.6% amid mounting concerns over its planned acquisition of Amedisys. The downturn stems from the Federal Trade
Johnson & Johnson Stock: Debt Concerns Rise After Strategic Acquisitions
Johnson & Johnson's financial stability faces new scrutiny as S&P Global Ratings places the healthcare giant's newly issued senior unsecured bonds under negative watch, despite maintaining their
Johnson & Johnson Aktie: Was jüngst diskutiert wird
Die Pharmasparte von Johnson & Johnson sorgte diese Woche für Aufsehen mit der Bekanntgabe des vorzeitigen Abbruchs ihrer Phase-3-Studie E.mbrace am 13. Februar 2025. Der Gesundheitskonzern, dessen
Pfizer Stock: Cancer Drug Study Shows Promising Results
Pfizer and Astellas Pharma have achieved a significant breakthrough in advanced bladder cancer treatment, demonstrating remarkable success with their combination therapy of PADCEV and KEYTRUDA. The
Unitedhealth Aktie: Aufwind im Geschäftsverlauf!
Die Tochtergesellschaft UMR der UnitedHealth Group hat sich zu einer bedeutenden Zahlung von mindestens 20,3 Millionen Dollar bereit erklärt, um eine Auseinandersetzung mit dem US-Arbeitsministerium
Pfizer Stock: Quarterly Results Show Strong Recovery Signs
Pfizer's recent quarterly performance demonstrates a significant turnaround, with revenues surging nearly 25% to reach $17.76 billion. The pharmaceutical giant has shown remarkable improvement in
Pfizer Stock: Q4 Surge Despite Market Dip
Pfizer's stock experienced a modest decline of 0.8% to $26.24 in Thursday's New York trading session, yet the pharmaceutical giant's underlying performance tells a more compelling story. The company
Pfizer Stock: AI Partnership Drives Strategic Transformation
Pharmaceutical giant Pfizer is embarking on a significant strategic shift with a heightened focus on artificial intelligence through a multi-year collaboration with technology firm Data4Cure. This
UnitedHealth Stock: Investor Allegations Trigger Share Decline
UnitedHealth Group faced market turbulence on Tuesday as its shares dropped approximately 1.5% following serious allegations from a prominent hedge fund manager. The investor raised concerns about
Pfizer Stock: Cancer Drug Study Shows Promising Results
Pfizer's recent breakthrough in cancer research is painting a promising picture for the pharmaceutical giant, despite its stock experiencing a slight dip of 0.9% to $26.27. The company has achieved
3 Stocks to Gain From Trump’s Family Caregiver Tax Credits
President Trump has endorsed the passage of a tax credit for family caregivers. The tax credit would be given to caregivers who take care of a parent, family member, or a loved one. The AARP
UnitedHealth Group Pulls Back Into Another Healthy Opportunity
UnitedHealth Group (NYSE: UNH) stock price is pulling back from highs set last year, presenting a healthy opportunity for investors. Although the outlook for revenue growth has dimmed, the
Can Integrated Healthcare Stocks Succeed in Public Markets?
America’s health insurance industry continues to face scrutiny after it was thrust into the headlines after the murder of UnitedHealth Group Inc. (NYSE: UNH) owned United Healthcare CEO Brian
BioNTech gibt auf der 43. J.P. Morgan Healthcare-Konferenz Updates zur Geschäfts- und Pipeline-Entwicklung
- BioNTech fokussiert sich in der Umsetzung der Onkologie-Strategie auf tumorübergreifende (Pan-Tumor-) Therapieansätze basierend auf Kombinationen mit BNT327/PM8002 sowie den
Top 3 Stocks Seeing a Spike in Call Option Volume
Volume is what drives the entire market, and that is a fact that often gets lost in the sea of indicators, patterns, and trend lines that dominate today’s concept of analysis. However, most
Pfizer: 4 Reasons to Buy This Stock
Pharmaceutical giant Pfizer Inc. (NYSE: PFE) stock is trading back down near its pandemic lows. Every time it attempts to climb over the $30 mark, something causes shares to slide right back down
Forget Teladoc and Buy This Healthcare Stock Instead
Telemedicine leader Teladoc Health (NYSE: TDOC) has been struggling for several years. The company's services are no longer experiencing the kind of demand they did during the pandemic years
Pfizer Is Still Struggling to Replace Its COVID Revenue. Here's What We Could See From the Pharmaceutical Giant in 2026.
It now seems so long ago that Pfizer (NYSE: PFE) became the first company in the biopharmaceutical industry to generate over $100 billion in annual sales. The drugmaker achieved this milestone
The Best Turnaround Stock to Invest $1,000 in Right Now
Even very well-run companies will eventually fall upon hard times. That's the backstory you need to keep in mind when you examine Bristol Myers Squibb (NYSE: BMY) and Pfizer (NYSE: PFE). Here's why
Down 50%, Should You Buy the Dip on Pfizer?
Pfizer (NYSE: PFE) is deeply unloved today. There are a couple of reasons for this that are important, but the big story revolves around the company's drug portfolio. With three drugs facing patent
Prediction: UnitedHealth Group Stock Will Soar in 2026
It's inaccurate to call the largest health insurer in the country and the fourth-largest healthcare company by market cap an underdog. However, UnitedHealth Group (NYSE: UNH) looked more like an